AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its product pipeline with experimental treatments ...

In the last months of his remarkable life, Bill Moyers spoke more frequently about the future than the past. He followed the first months of the second Trump presidency with mounting concern ...